Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
One or two hydroxychloroquine tablets can seriously poison a small child. Here is how the drug affects potassium and the heart, and how emergency teams treat it.
Long-term hydroxychloroquine can rarely damage heart muscle by clogging the cell's recycling system. Here is how it happens, which ECG changes matter, and how biopsy confirms it.
Hydroxychloroquine can damage the retina after years of use. Here is how weight-based dosing, OCT and visual field testing, and timing work together to catch it early.
For pregnant women with lupus, continuing hydroxychloroquine lowers flare risk and appears safe for the baby. It may also reduce the risk of congenital heart block in anti-Ro-positive mothers.
Hydroxychloroquine, chloroquine, and primaquine all carry warnings for G6PD deficiency, but their actual hemolysis risk differs sharply by chemistry and dose.
Hydroxychloroquine fights malaria and calms lupus through the same basic trick: making acidic cellular compartments less acidic.
How a bark-derived remedy from the Andes led to two related drugs, and why parasite resistance—not hydroxychloroquine—became malaria's real challenge.
Why hydroxychloroquine takes months to work and months to leave the body—and how its unusual pharmacokinetics shape dosing in lupus and rheumatoid arthritis.
Hydroxychloroquine can slowly damage the retina after years of use. Here's what the evidence shows about who is most at risk and why regular eye exams matter.